Taylor & Francis
+4
1746-045X
Monthly
6.0
1746-0441
2006
4402080520500
YES
United Kingdom
English
YES
GOOGLE SCHOLAR
enquiries@taylorandfrancis.com
Expert Opinion on Drug Discovery (1746-0441; 1746-045X) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug discovery. Expert Opinion on Drug Discovery publishes original research and review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimization at the preclinical level. Articles focus on the following key areas: Chemoinformatics Bioinformatics Assay development Novel screening technologies In vitro/in vivo models Structure-based drug design Systems biology
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.